| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
Bambusa Therapeutics, Inc.
13G
058937103
|
9.2% |
11/5/2026
Event 10/29/2026
|
||||
| Athos KG | 9.0% | |||||
| Objektgesellschaft Salzufer 1 GmbH | 9.0% | |||||
| Salzufer Holding Inc. | 9.0% | |||||
| Thomas Maier | 9.2% | |||||
|
BioNTech SE
13G/A
BNTX · 09075V102
|
40.2% |
5/14/2026
Event 3/31/2026
|
||||
| Athos KG | 40.2% | |||||
| AT Impf GmbH | 40.2% | |||||
| Thomas Maier | 40.2% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.